SCHEMBL11941384

SCHEMBL11941384

O=C(/C=C/c1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1ccc(O)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HB P07237 3/20 0.76
CYP1B1 Q16678 6/20 0.75
CYP1A1 P04798 5/20 0.75
F3 P13726 2/20 0.62
MAOB P27338 6/20 0.59
MAPT P10636 2/20 0.57
MAOA P21397 2/20 0.57
CYP3A4 P08684 2/20 0.57
HSPD1 P10809 2/20 0.57
HSPE1 P61604 2/20 0.57
KMT2A Q03164 2/20 0.57
MEN1 O00255 1/20 0.57
ALDH2 P05091 1/20 0.57
CYP19A1 P11511 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
ABCG2 Q9UNQ0 1/20 0.55
CXCL12 P48061 2/20 0.54
RAB9A P51151 2/20 0.54
ESR1 P03372 1/20 0.54
ESR2 Q92731 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11937146 0.90 P4HB (0.67) P4HBCYP1B1CYP1A1F3MAOB
SCHEMBL25199747 0.87 P4HB (1.00) P4HBCYP1B1CYP1A1F3MAOB
SCHEMBL25221835 0.87 P4HB (1.00) P4HBCYP1B1CYP1A1F3MAOB
SCHEMBL25192715 0.86 CYP1B1 (1.00) P4HBCYP1B1CYP1A1F3MAOB
SCHEMBL20244279 0.86 CYP1B1 (1.00) P4HBCYP1B1CYP1A1F3MAOB
SCHEMBL3059923 0.84 P4HB (0.63) P4HBCYP1B1CYP1A1MAOBABCG2
SCHEMBL3059926 0.84 P4HB (0.63) P4HBCYP1B1CYP1A1MAOBABCG2
SCHEMBL25375955 0.82 MAOB (0.79) P4HBCYP1B1CYP1A1F3MAOB
SCHEMBL4910956 0.80 CYP1B1 (0.67) P4HBCYP1B1CYP1A1MAOBCYP3A4
SCHEMBL2647645 0.79 MEN1 (0.55) P4HBCYP1B1CYP1A1MAOBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120277252-A1 Antibacterial Agents and Methods of Use Thereof WISCONSIN ALUMNI RESEARCH FOUNDATION 2012-11-01 US disclosed
US-8227616-B2 Cyanopyridine antibacterial agents and methods of use thereof WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2012-07-24 US disclosed
US-20100261763-A1 ANTIBACTERIAL AGENTS AND METHODS OF USE THEREOF WISCONSIN ALUMNI RESEARCH FOUNDATION 2010-10-14 US disclosed
US-7737164-B2 Cyanopyridine antibacterial agents WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2010-06-15 US disclosed
WO-2008016738-A2 ANTIBACTERIAL AGENTS AND RELATED SCREENING METHODS USING SMALL MOLECULE MACROARRAYS WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2008-02-07 WO disclosed
US-20080009528-A1 ANTIBACTERIAL AGENTS AND RELATED SCREENING METHODS USING SMALL MOLECULE MACROARRAYS WISCONSIN ALUMNI RESEARCH FOUNDATION 2008-01-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120277252-A1 Antibacterial Agents and Methods of Use Thereof FDPS, ABCG2, DUT P4HB 2360/4885CYP1B1 373/4885CYP1A1 634/4885
US-20080009528-A1 ANTIBACTERIAL AGENTS AND RELATED SCREENING METHODS USING SMALL MOLECULE MACROARRAYS PCNA, ABCG2, API5 P4HB 3790/4885CYP1B1 760/4885CYP1A1 1017/4885
US-20100261763-A1 ANTIBACTERIAL AGENTS AND METHODS OF USE THEREOF FDPS, CYP3A5, ABCG2 P4HB 2537/4885CYP1B1 324/4885CYP1A1 536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.